GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Shiller PE Ratio
中文

Sumitomo Pharma Co (Sumitomo Pharma Co) Shiller PE Ratio : 10.00 (As of Apr. 24, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Shiller PE Ratio?

As of today (2024-04-24), Sumitomo Pharma Co's current share price is $2.70. Sumitomo Pharma Co's E10 for the quarter that ended in Dec. 2023 was $0.27. Sumitomo Pharma Co's Shiller PE Ratio for today is 10.00.

The historical rank and industry rank for Sumitomo Pharma Co's Shiller PE Ratio or its related term are showing as below:

DNPUF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 7.49   Med: 21.67   Max: 61.38
Current: 10

During the past years, Sumitomo Pharma Co's highest Shiller PE Ratio was 61.38. The lowest was 7.49. And the median was 21.67.

DNPUF's Shiller PE Ratio is ranked better than
88.72% of 514 companies
in the Drug Manufacturers industry
Industry Median: 24.405 vs DNPUF: 10.00

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sumitomo Pharma Co's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.874. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.27 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sumitomo Pharma Co Shiller PE Ratio Historical Data

The historical data trend for Sumitomo Pharma Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Shiller PE Ratio Chart

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.78 20.31 24.43 13.16 11.05

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.71 11.05 10.18 9.74 11.71

Competitive Comparison of Sumitomo Pharma Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Shiller PE Ratio falls into.



Sumitomo Pharma Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sumitomo Pharma Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2.70/0.27
=10.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Sumitomo Pharma Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.874/106.8000*106.8000
=-0.874

Current CPI (Dec. 2023) = 106.8000.

Sumitomo Pharma Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.022 95.700 0.025
201406 0.142 98.000 0.155
201409 0.141 98.500 0.153
201412 0.153 97.900 0.167
201503 -0.074 97.900 -0.081
201506 0.121 98.400 0.131
201509 0.152 98.500 0.165
201512 0.210 98.100 0.229
201603 0.030 97.900 0.033
201606 0.200 98.100 0.218
201609 0.063 98.000 0.069
201612 0.405 98.400 0.440
201703 0.039 98.100 0.042
201706 0.559 98.500 0.606
201709 0.471 98.800 0.509
201712 -0.032 99.400 -0.034
201803 0.227 99.200 0.244
201806 0.349 99.200 0.376
201809 0.283 99.900 0.303
201812 0.271 99.700 0.290
201903 0.196 99.700 0.210
201906 0.156 99.800 0.167
201909 0.553 100.100 0.590
201912 0.315 100.500 0.335
202003 -0.075 100.300 -0.080
202006 0.427 99.900 0.456
202009 0.454 99.900 0.485
202012 0.799 99.300 0.859
202103 -0.325 99.900 -0.347
202106 0.110 99.500 0.118
202109 0.723 100.100 0.771
202112 0.219 100.100 0.234
202203 0.213 101.100 0.225
202206 0.584 101.800 0.613
202209 -0.674 103.100 -0.698
202212 -0.209 104.100 -0.214
202303 -1.055 104.400 -1.079
202306 -0.692 105.200 -0.703
202309 -0.492 106.200 -0.495
202312 -0.874 106.800 -0.874

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sumitomo Pharma Co  (OTCPK:DNPUF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Sumitomo Pharma Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.